• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于小干扰RNA递送的壳聚糖及其结构修饰

Chitosan and Its Structural Modifications for siRNA Delivery.

作者信息

Al-Absi Mona Y, Caprifico Anna Eleonora, Calabrese Gianpiero

机构信息

School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston upon Thames, KT1 2EE, United Kingdom.

出版信息

Adv Pharm Bull. 2023 Mar;13(2):275-282. doi: 10.34172/apb.2023.030. Epub 2022 Jan 8.

DOI:10.34172/apb.2023.030
PMID:37342385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10278227/
Abstract

The use of RNA interference mechanism and small interfering RNA (siRNA) in cancer gene therapy is a very promising approach. However, the success of gene silencing is underpinned by the efficient delivery of intact siRNA into the targeted cell. Nowadays, chitosan is one of the most widely studied non-viral vectors for siRNA delivery, since it is a biodegradable, biocompatible and positively charged polymer able to bind to the negatively charged siRNA forming nanoparticles (NPs) that will act as siRNA delivery system. However, chitosan shows several limitations such as low transfection efficiency and low solubility at physiological pH. Therefore, a variety of chemical and non-chemical structural modifications of chitosan were investigated in the attempt to develop a chitosan derivative showing the features of an ideal siRNA carrier. In this review, the most recently proposed chemical modifications of chitosan are outlined. The type of modification, chemical structure, physicochemical properties, siRNA binding affinity and complexation efficiency of the modified chitosan are discussed. Moreover, the resulting NPs characteristics, cellular uptake, serum stability, cytotoxicity and gene transfection efficiency and/or are described and compared to the unmodified chitosan. Finally, a critical analysis of a selection of modifications is included, highlighting the most promising ones for this purpose in the future.

摘要

在癌症基因治疗中使用RNA干扰机制和小干扰RNA(siRNA)是一种非常有前景的方法。然而,基因沉默的成功取决于完整的siRNA有效递送至靶细胞。如今,壳聚糖是用于siRNA递送研究最广泛的非病毒载体之一,因为它是一种可生物降解、生物相容且带正电荷的聚合物,能够与带负电荷的siRNA结合形成纳米颗粒(NP),这些纳米颗粒将作为siRNA递送系统。然而,壳聚糖存在一些局限性,如转染效率低和在生理pH下溶解度低。因此,人们研究了壳聚糖的各种化学和非化学结构修饰,试图开发出一种具有理想siRNA载体特性的壳聚糖衍生物。在这篇综述中,概述了最近提出的壳聚糖化学修饰。讨论了修饰类型、化学结构、物理化学性质、siRNA结合亲和力和修饰壳聚糖的络合效率。此外,还描述了所得纳米颗粒的特性、细胞摄取、血清稳定性、细胞毒性和基因转染效率,并与未修饰的壳聚糖进行了比较。最后,对一系列修饰进行了批判性分析,突出了未来在此方面最有前景的修饰。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/753b80a25044/apb-13-275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/88278f7df580/apb-13-275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/cbcaf5595aa0/apb-13-275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/6fb551aff4c0/apb-13-275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/753b80a25044/apb-13-275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/88278f7df580/apb-13-275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/cbcaf5595aa0/apb-13-275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/6fb551aff4c0/apb-13-275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0666/10278227/753b80a25044/apb-13-275-g004.jpg

相似文献

1
Chitosan and Its Structural Modifications for siRNA Delivery.用于小干扰RNA递送的壳聚糖及其结构修饰
Adv Pharm Bull. 2023 Mar;13(2):275-282. doi: 10.34172/apb.2023.030. Epub 2022 Jan 8.
2
Chitosan as a carrier for targeted delivery of small interfering RNA.壳聚糖作为小干扰 RNA 靶向递送的载体。
Int J Pharm. 2010 Oct 31;399(1-2):1-11. doi: 10.1016/j.ijpharm.2010.08.022. Epub 2010 Aug 21.
3
Chemical modification of chitosan with pH-sensitive molecules and specific ligands for efficient DNA transfection and siRNA silencing.用pH敏感分子和特异性配体对壳聚糖进行化学修饰以实现高效DNA转染和siRNA沉默。
J Nanosci Nanotechnol. 2014 Jan;14(1):564-76. doi: 10.1166/jnn.2014.9079.
4
In Vitro Cellular Uptake and Transfection of Oligoarginine-Conjugated Glycol Chitosan/siRNA Nanoparticles.寡聚精氨酸偶联的壳聚糖/小干扰RNA纳米颗粒的体外细胞摄取与转染
Polymers (Basel). 2021 Dec 1;13(23):4219. doi: 10.3390/polym13234219.
5
Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.用于在肝癌细胞中进行中期因子小干扰RNA细胞内递送的混合型修饰壳聚糖衍生物纳米颗粒的研发
Hepatobiliary Pancreat Dis Int. 2015 Feb;14(1):82-9. doi: 10.1016/s1499-3872(15)60336-8.
6
Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.用于通过血脑屏障靶向递送 siRNA 的抗体修饰壳聚糖纳米粒的开发,作为抑制星形胶质细胞中 HIV 复制的策略。
Drug Deliv Transl Res. 2017 Aug;7(4):497-506. doi: 10.1007/s13346-017-0368-5.
7
Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.mPEG-PLGA-PLL 三嵌段共聚物的可生物降解纳米粒作为新型非病毒载体提高 siRNA 传递和基因沉默效率。
Int J Mol Sci. 2012;13(1):516-533. doi: 10.3390/ijms13010516. Epub 2012 Jan 4.
8
Novel Ellipsoid Chitosan-Phthalate Lecithin Nanoparticles for siRNA Delivery.用于小干扰RNA递送的新型椭球形壳聚糖 - 邻苯二甲酸卵磷脂纳米颗粒
Front Bioeng Biotechnol. 2021 Jul 28;9:695371. doi: 10.3389/fbioe.2021.695371. eCollection 2021.
9
Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.叶酸偶联低相对分子质量壳聚糖用于体外 siRNA 递送:优化研究。
Int J Nanomedicine. 2012;7:5833-45. doi: 10.2147/IJN.S35567. Epub 2012 Nov 23.
10
Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.用于荷瘤小鼠体内 siRNA 系统递送的肿瘤归巢性乙二醇壳聚糖/聚乙烯亚胺纳米粒。
J Control Release. 2010 Jun 1;144(2):134-43. doi: 10.1016/j.jconrel.2010.02.023. Epub 2010 Feb 22.

引用本文的文献

1
Recent advancements in polymer science for retinal diseases: New frontiers in drug delivery systems.用于视网膜疾病的聚合物科学的最新进展:药物递送系统的新前沿。
APL Bioeng. 2025 Jun 27;9(2):020902. doi: 10.1063/5.0264382. eCollection 2025 Jun.
2
Engineered Chitosan-Derived Nanocarrier for Efficient siRNA Delivery to Peripheral and Central Neurons.用于高效将小干扰RNA递送至外周和中枢神经元的工程化壳聚糖衍生纳米载体
Adv Healthc Mater. 2025 Jun;14(15):e2500107. doi: 10.1002/adhm.202500107. Epub 2025 May 13.
3
Advances in the Study of Age-Related Macular Degeneration Based on Cell or Cell-Biomaterial Scaffolds.

本文引用的文献

1
Chitosan-based nanodelivery systems for cancer therapy: Recent advances.用于癌症治疗的壳聚糖基纳米递送系统:最新进展
Carbohydr Polym. 2021 Nov 15;272:118464. doi: 10.1016/j.carbpol.2021.118464. Epub 2021 Jul 21.
2
Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy.壳聚糖基纳米递药系统在生物医学中的应用:在癌症治疗中siRNA 递呈的潜在用途。
Carbohydr Polym. 2021 May 15;260:117809. doi: 10.1016/j.carbpol.2021.117809. Epub 2021 Feb 16.
3
Chitosan as a machine for biomolecule delivery: A review.
基于细胞或细胞-生物材料支架的年龄相关性黄斑变性研究进展
Bioengineering (Basel). 2025 Mar 11;12(3):278. doi: 10.3390/bioengineering12030278.
4
Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection.壳聚糖纳米颗粒基因治疗:增强癌细胞转染的现代制剂策略
Pharmaceutics. 2024 Jun 27;16(7):868. doi: 10.3390/pharmaceutics16070868.
5
Smart Physicochemical-triggered Chitosan-based Nanogels for siRNA Delivery and Gene Therapy: A Focus on Emerging Strategies and Paradigms for Cancer Therapy.用于 siRNA 递送和基因治疗的智能物理化学触发的壳聚糖基纳米凝胶:聚焦癌症治疗的新兴策略和范例
Curr Med Chem. 2024 Jun 5. doi: 10.2174/0109298673286052240426044945.
6
Implications of siRNA Therapy in Bone Health: Silencing Communicates.小干扰RNA疗法对骨骼健康的影响:沉默进行交流。
Biomedicines. 2024 Jan 1;12(1):90. doi: 10.3390/biomedicines12010090.
7
Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives.用于核酸递送的壳聚糖基纳米颗粒:技术层面、应用及未来展望
Pharmaceutics. 2023 Jun 29;15(7):1849. doi: 10.3390/pharmaceutics15071849.
壳聚糖作为生物分子递药载体:综述。
Carbohydr Polym. 2021 Mar 15;256:117414. doi: 10.1016/j.carbpol.2020.117414. Epub 2020 Nov 21.
4
Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.克服血脑屏障转运:基于纳米颗粒的药物递送策略进展
Mater Today (Kidlington). 2020 Jul-Aug;37:112-125. doi: 10.1016/j.mattod.2020.02.001. Epub 2020 Mar 4.
5
Recent Advances in Chitosan-Based Carriers for Gene Delivery.壳聚糖基载体在基因传递中的最新进展。
Mar Drugs. 2019 Jun 25;17(6):381. doi: 10.3390/md17060381.
6
Amphipathic chitosans improve the physicochemical properties of siRNA-chitosan nanoparticles at physiological conditions.两亲性壳聚糖可改善生理条件下 siRNA-壳聚糖纳米粒的理化性质。
Carbohydr Polym. 2019 Jul 15;216:332-342. doi: 10.1016/j.carbpol.2019.03.098. Epub 2019 Mar 28.
7
Chitosan for gene delivery: Methods for improvement and applications.壳聚糖作为基因传递载体:改良方法与应用。
Adv Colloid Interface Sci. 2019 Jun;268:25-38. doi: 10.1016/j.cis.2019.03.007. Epub 2019 Mar 21.
8
Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.二乙氨基乙基壳聚糖作为 siRNA 递送的有效载体:改善凝聚过程和纳米颗粒性质。
Int J Biol Macromol. 2018 Nov;119:186-197. doi: 10.1016/j.ijbiomac.2018.07.072. Epub 2018 Jul 18.
9
Synthesis, characterization, and in vitro cytotoxicity of fatty acyl-CGKRK-chitosan oligosaccharides conjugates for siRNA delivery.脂肪酸酰基-CGKRK-壳聚糖寡糖缀合物的合成、表征及其作为 siRNA 递送载体的体外细胞毒性。
Int J Biol Macromol. 2018 Jun;112:694-702. doi: 10.1016/j.ijbiomac.2018.01.213. Epub 2018 Feb 2.
10
siRNA Delivery with Chitosan: Influence of Chitosan Molecular Weight, Degree of Deacetylation, and Amine to Phosphate Ratio on in Vitro Silencing Efficiency, Hemocompatibility, Biodistribution, and in Vivo Efficacy.壳聚糖介导的 siRNA 递送:壳聚糖分子量、脱乙酰度和胺基与磷酸酯比值对体外沉默效率、血液相容性、生物分布和体内疗效的影响。
Biomacromolecules. 2018 Jan 8;19(1):112-131. doi: 10.1021/acs.biomac.7b01297. Epub 2017 Dec 28.